U.S. flag

An official website of the United States government

NM_002075.4(GNB3):c.825C>T (p.Ser275=) AND Hypertension, essential, susceptibility to

Germline classification:
risk factor (1 submission)
Last evaluated:
Apr 1, 2003
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001824025.9

Allele description [Variation Report for NM_002075.4(GNB3):c.825C>T (p.Ser275=)]

NM_002075.4(GNB3):c.825C>T (p.Ser275=)

Genes:
GNB3:G protein subunit beta 3 [Gene - OMIM - HGNC]
CDCA3:cell division cycle associated 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12p13.31
Genomic location:
Preferred name:
NM_002075.4(GNB3):c.825C>T (p.Ser275=)
HGVS:
  • NC_000012.12:g.6845711C>T
  • NG_009100.2:g.10501C>T
  • NM_001297571.2:c.822C>T
  • NM_001297603.3:c.*1077G>A
  • NM_002075.4:c.825C>TMANE SELECT
  • NP_001284500.1:p.Ser274=
  • NP_002066.1:p.Ser275=
  • NC_000012.11:g.6954875C>T
  • NM_002075.3:c.825C>T
Nucleotide change:
825C-T
Links:
PharmGKB Clinical Annotation: 655385125; OMIM: 139130.0001; dbSNP: rs5443
NCBI 1000 Genomes Browser:
rs5443
Molecular consequence:
  • NM_001297603.3:c.*1077G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001297571.2:c.822C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_002075.4:c.825C>T - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Hypertension, essential, susceptibility to
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000037649OMIM
no assertion criteria provided
risk factor
(Apr 1, 2003)
germlineliterature only

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Association of a human G-protein beta3 subunit variant with hypertension.

Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B.

Nat Genet. 1998 Jan;18(1):45-8.

PubMed [citation]
PMID:
9425898

G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit.

Hegele RA, Anderson C, Young TK, Connelly PW.

Genome Res. 1999 Oct;9(10):972-7.

PubMed [citation]
PMID:
10523525
PMCID:
PMC310817
See all PubMed Citations (8)

Details of each submission

From OMIM, SCV000037649.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (8)

Description

Siffert et al. (1998) described an 825C-T polymorphism in exon 10 of the gene encoding the beta-3 subunit of heterotrimeric G proteins. The T allele was associated with a splice variant in which nucleotides 498-620 of exon 9 were deleted. This in-frame deletion caused the loss of 41 amino acids and 1 WD repeat domain of the beta subunit. Increased activity of the splice variant was thought to be responsible for the previously observed enhanced signal transduction via pertussis toxin-sensitive G proteins in lymphoblasts and fibroblasts from selected patients with essential hypertension. The T allele in homozygous or heterozygous state were found in 44% of normotensive subjects and in 53.1% of hypertensive subjects.

Hegele et al. (1999) found an increased body mass index among Canadian Inuits who were homozygous for the 825T allele. Siffert et al. (1999) found increased body mass index in 825T homozygotes of Caucasian, Chinese, and black-African ethnicity. Hocher et al. (2000) found an association between maternal G protein beta-3 825T allele and low birth weight in babies born to women without other risks for reduced fetal growth. Gutersohn et al. (2000) found that sedentary primiparous women homozygous for the 825T allele retained more weight after delivery, as compared with women with at least 1 825C allele. Feldman and Hegele (2000) commented on the aforementioned studies.

Lindemann et al. (2001) demonstrated that the C825T allele influences cellular immune responses toward recall antigens and interleukin-2 (IL2; 147680) stimulation. Responses were increased 2- to 4-fold in homozygous 825T peripheral blood mononuclear cells compared with cells from homozygous 825C individuals. Furthermore, lymphocyte chemotaxis and CD4 (186940)-positive T-cell counts were significantly enhanced in individuals homozygous or heterozygous for the 825T allele. Lindemann et al. (2001) concluded that 825T allele status is predictive of immunocompetence and that GNB3 could be a candidate gene in disorders associated with inadequate immune response.

The 825C-T polymorphism has been associated with obesity in several ethnic groups (Siffert et al., 1999), and with body mass index (BMI) the first year after pregnancy (Gutersohn et al., 2000), as well as with low birth weight (Hocher et al., 2000). Dishy et al. (2003) showed that the women homozygous for the T allele (TT) gained significantly more weight than women carrying the C allele (CC and CT groups) (P = 0.006) and had a significantly higher prepregnancy BMI (p = 0.02).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 30, 2024